# Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

> **NCT05106699** · NA · RECRUITING · sponsor: **Shanghai Proton and Heavy Ion Center** · enrollment: 54 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** proton plus carbon ion radiation

## Key facts

- **NCT ID:** NCT05106699
- **Lead sponsor:** Shanghai Proton and Heavy Ion Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-08
- **Primary completion:** 2025-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05106699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05106699, "Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05106699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*